XPH vs. FTXH ETF Comparison
Comparison of SPDR S&P Pharmaceuticals ETF (XPH) to First Trust Nasdaq Pharmaceuticals ETF (FTXH)
XPH
SPDR S&P Pharmaceuticals ETF
XPH Description
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a replication strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.
Grade (RS Rating)
Last Trade
$46.16
Average Daily Volume
40,383
44
FTXH
First Trust Nasdaq Pharmaceuticals ETF
FTXH Description
The First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an index called the Nasdaq US Smart Pharmaceuticals Index. The Fund seeks to replicate the holdings and weightings of the Nasdaq US Smart Pharmaceuticals Index so as to generate performance results 95% correlated to that of the Nasdaq US Smart Pharmaceuticals Index.Grade (RS Rating)
Last Trade
$28.34
Average Daily Volume
3,896
50
Performance
| Period | XPH | FTXH |
|---|---|---|
| 30 Days | 4.18% | -1.15% |
| 60 Days | 3.86% | -4.04% |
| 90 Days | 9.06% | -0.60% |
| 12 Months | 28.77% | 17.83% |
15 Overlapping Holdings
| Symbol | Grade | Weight in XPH | Weight in FTXH | Overlap | |
|---|---|---|---|---|---|
| AMRX | B | 1.24% | 0.5% | 0.5% | |
| BMY | A | 3.75% | 8.0% | 3.75% | |
| CORT | B | 4.32% | 0.7% | 0.7% | |
| ELAN | D | 2.98% | 1.61% | 1.61% | |
| ITCI | A | 3.49% | 0.54% | 0.54% | |
| JAZZ | D | 3.46% | 2.99% | 2.99% | |
| JNJ | D | 3.44% | 7.45% | 3.44% | |
| LLY | F | 3.36% | 3.5% | 3.36% | |
| MRK | F | 3.18% | 6.75% | 3.18% | |
| OGN | D | 2.93% | 2.72% | 2.72% | |
| PBH | A | 2.22% | 0.86% | 0.86% | |
| PFE | D | 3.41% | 7.45% | 3.41% | |
| PRGO | D | 3.15% | 0.9% | 0.9% | |
| VTRS | B | 3.43% | 3.59% | 3.43% | |
| ZTS | D | 3.31% | 3.73% | 3.31% |
XPH Overweight 29 Positions Relative to FTXH
| Symbol | Grade | Weight | |
|---|---|---|---|
| LBPH | A | 4.15% | |
| EWTX | B | 3.64% | |
| CTLT | D | 3.47% | |
| RPRX | D | 3.43% | |
| AXSM | C | 3.3% | |
| ARVN | C | 2.76% | |
| SAVA | D | 2.7% | |
| TARS | A | 2.36% | |
| AMPH | A | 2.25% | |
| SUPN | B | 2.03% | |
| PCRX | C | 2.01% | |
| LGND | A | 1.72% | |
| COLL | F | 1.69% | |
| OCUL | B | 1.59% | |
| ANIP | F | 1.57% | |
| HROW | C | 1.46% | |
| HRMY | D | 1.27% | |
| WVE | B | 1.16% | |
| INVA | C | 1.02% | |
| LQDA | C | 0.99% | |
| PLRX | A | 0.93% | |
| MNMD | C | 0.9% | |
| EYPT | C | 0.87% | |
| PHAT | B | 0.87% | |
| FULC | F | 0.83% | |
| ELVN | B | 0.75% | |
| EOLS | A | 0.7% | |
| NUVB | F | 0.49% | |
| XERS | A | 0.49% |
XPH Underweight 35 Positions Relative to FTXH
| Symbol | Grade | Weight | |
|---|---|---|---|
| ABBV | A | -7.29% | |
| GILD | A | -4.24% | |
| CAH | B | -3.76% | |
| AMGN | C | -3.57% | |
| UTHR | A | -3.51% | |
| BIIB | F | -3.39% | |
| REGN | F | -2.96% | |
| CRL | F | -2.28% | |
| MEDP | F | -1.75% | |
| NBIX | C | -1.3% | |
| HALO | B | -1.08% | |
| ALKS | F | -1.0% | |
| EXEL | A | -0.89% | |
| PTGX | B | -0.8% | |
| ALNY | C | -0.73% | |
| ACLX | B | -0.66% | |
| EXAS | A | -0.6% | |
| VKTX | A | -0.6% | |
| RNA | C | -0.54% | |
| KYMR | C | -0.53% | |
| TGTX | A | -0.52% | |
| INCY | A | -0.52% | |
| ROIV | D | -0.51% | |
| SRPT | D | -0.51% | |
| VRTX | D | -0.5% | |
| TWST | F | -0.49% | |
| INSM | D | -0.49% | |
| ADMA | B | -0.48% | |
| KRYS | C | -0.47% | |
| BPMC | C | -0.46% | |
| ACAD | F | -0.46% | |
| BMRN | F | -0.45% | |
| VCEL | D | -0.44% | |
| IONS | F | -0.43% | |
| MYGN | F | -0.4% |
XPH: Top Represented Industries & Keywords
FTXH: Top Represented Industries & Keywords
Compare ETFs
